Kinetics of a high dose of piretanide in renal failure
- 1 January 1982
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 21 (4) , 307-310
- https://doi.org/10.1007/bf00637618
Abstract
The kinetics of piretanide was studied in patients with renal failure. After oral administration of a high dose of piretanide (96 mg), the pharmacokinetic parameters were: elimination rate constant 0.346±0.072 h−1, half life 2.00±0.35 h, and total plasma clearance 119.55±35.90 ml · min−1. Compared to the values obtained in adults with normal renal function, these results show a decrease in total plasma clearance, but conservation of the metabolic clearance which amounts to 45% of the total clearance in the healthy adult.This publication has 9 references indexed in Scilit:
- Activity of a new high efficiency diuretic in man: piretanide (HOE 118).Published by Wiley ,1980
- Effects of a new diuretic (piretanide) compared with furosemide on renal diluting and concentrating mechanisms in patients with the nephrotic syndromeEuropean Journal of Clinical Pharmacology, 1980
- Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremiaClinical Pharmacology & Therapeutics, 1978
- Furosemide kinetics in renal failureClinical Pharmacology & Therapeutics, 1978
- Kinetic and dynamic comparison of piretanide and furosemideClinical Pharmacology & Therapeutics, 1978
- Elimination of furosemide in healthy subjects and in those with renal failureClinical Pharmacology & Therapeutics, 1977
- Pharmacokinetics of furosemide in advanced renal failureClinical Pharmacology & Therapeutics, 1974
- Pharmacokinetics of furosemide in normal subjects and functionally anephric patientsClinical Pharmacology & Therapeutics, 1974
- Pharmacokinetics and Pharmacodynamics of LasixScottish Medical Journal, 1974